Policymaker Perspectives on Implementation Determinants of Rapid ART and Same-Day PrEP in Seven Priority Jurisdictions for Ending the HIV Epidemic: A Multisite Qualitative Study.

IF 2.9 3区 医学 Q3 IMMUNOLOGY
Anna-Sophia Katomski, Ana Michaela Pachicano, Alithia Zamantakis, Nanette D Benbow, Cathleen Willging, Joseph G Rosen, Elena P Rosenberg-Carlson, Wilson Gomez, Alison B Hamilton, Jessica E Kassanits, Robin Gaines Lanzi, Joyce L Jones, Tequetta Valeriano, Russell A Brewer, Aadia I Rana, Uyen Kao, Maile Karris, Jill Blumenthal, Sheree R Schwartz, Laura K Beres
{"title":"Policymaker Perspectives on Implementation Determinants of Rapid ART and Same-Day PrEP in Seven Priority Jurisdictions for Ending the HIV Epidemic: A Multisite Qualitative Study.","authors":"Anna-Sophia Katomski, Ana Michaela Pachicano, Alithia Zamantakis, Nanette D Benbow, Cathleen Willging, Joseph G Rosen, Elena P Rosenberg-Carlson, Wilson Gomez, Alison B Hamilton, Jessica E Kassanits, Robin Gaines Lanzi, Joyce L Jones, Tequetta Valeriano, Russell A Brewer, Aadia I Rana, Uyen Kao, Maile Karris, Jill Blumenthal, Sheree R Schwartz, Laura K Beres","doi":"10.1097/QAI.0000000000003619","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Although rapid antiretroviral therapy (ART) and same-day pre-exposure prophylaxis models (henceforth \"rapid START\") are feasible, acceptable, and cost-effective in various contexts, significant barriers have hindered their broader implementation and scalability in the United States. Ryan White-funded clinics are cornerstones for HIV services, yet strategies are urgently needed to facilitate equitable rapid START adoption across contexts. This study aimed to identify common factors influencing rapid START to inform strategies applicable throughout jurisdictional settings.</p><p><strong>Methods: </strong>The Network for Implementation Science in HIV examined the current implementation of rapid START among diverse Ryan White Part A-D-funded organizations across seven Ending the HIV Epidemic jurisdictions across the United States. Semistructured interviews (n = 13) were administered from March 2023 to August 2024, with HIV leadership across jurisdictions to identify rapid START implementation determinants and strategies to catalyze rapid START delivery. Data were deductively analyzed using the Consolidated Framework for Implementation Research.</p><p><strong>Results: </strong>Prominent barriers to rapid ART implementation across settings included provider/patient hesitancy and awareness gaps, siloed care systems, and funding complexities. Prominent implementation facilitators included learning collaboratives, technology integration, and clear contracting language. Key constraints to same-day pre-exposure prophylaxis implementation included funding inequities and suboptimal client/patient awareness, whereas enablers included integrated care models, availability of starter packs, and medication-assistance programs.</p><p><strong>Conclusions: </strong>Several consistent key barriers and facilitators spanned multiple Ending the HIV Epidemic jurisdictions despite contextual differences (eg, Medicaid expansion). Collaborative efforts between system leaders and service providers were universally characterized as essential for equitable adoption and penetration of rapid START models.</p>","PeriodicalId":14588,"journal":{"name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","volume":"98 5S","pages":"e192-e204"},"PeriodicalIF":2.9000,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAIDS Journal of Acquired Immune Deficiency Syndromes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QAI.0000000000003619","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Although rapid antiretroviral therapy (ART) and same-day pre-exposure prophylaxis models (henceforth "rapid START") are feasible, acceptable, and cost-effective in various contexts, significant barriers have hindered their broader implementation and scalability in the United States. Ryan White-funded clinics are cornerstones for HIV services, yet strategies are urgently needed to facilitate equitable rapid START adoption across contexts. This study aimed to identify common factors influencing rapid START to inform strategies applicable throughout jurisdictional settings.

Methods: The Network for Implementation Science in HIV examined the current implementation of rapid START among diverse Ryan White Part A-D-funded organizations across seven Ending the HIV Epidemic jurisdictions across the United States. Semistructured interviews (n = 13) were administered from March 2023 to August 2024, with HIV leadership across jurisdictions to identify rapid START implementation determinants and strategies to catalyze rapid START delivery. Data were deductively analyzed using the Consolidated Framework for Implementation Research.

Results: Prominent barriers to rapid ART implementation across settings included provider/patient hesitancy and awareness gaps, siloed care systems, and funding complexities. Prominent implementation facilitators included learning collaboratives, technology integration, and clear contracting language. Key constraints to same-day pre-exposure prophylaxis implementation included funding inequities and suboptimal client/patient awareness, whereas enablers included integrated care models, availability of starter packs, and medication-assistance programs.

Conclusions: Several consistent key barriers and facilitators spanned multiple Ending the HIV Epidemic jurisdictions despite contextual differences (eg, Medicaid expansion). Collaborative efforts between system leaders and service providers were universally characterized as essential for equitable adoption and penetration of rapid START models.

决策者对七个优先辖区快速抗逆转录病毒治疗和当日预防措施实施决定因素的看法,以结束艾滋病毒流行:一项多地点定性研究。
背景:尽管快速抗逆转录病毒治疗(ART)和当日暴露前预防模式(以下简称“快速启动”)在各种情况下是可行的、可接受的和具有成本效益的,但重大障碍阻碍了它们在美国的广泛实施和可扩展性。Ryan white资助的诊所是艾滋病毒服务的基石,但迫切需要战略来促进在不同情况下公平快速地采用START。本研究旨在确定影响快速启动的共同因素,为适用于整个司法管辖区的战略提供信息。方法:艾滋病毒实施科学网络检查了美国七个终止艾滋病毒流行管辖区的瑞安·怀特a - d部分资助的不同组织目前实施快速START的情况。从2023年3月到2024年8月进行了半结构化访谈(n = 13),与各司法管辖区的艾滋病毒领导一起确定快速实施START的决定因素和战略,以促进快速实施START。使用实施研究统一框架对数据进行演绎分析。结果:跨环境快速实施抗逆转录病毒治疗的主要障碍包括提供者/患者的犹豫和意识差距、孤立的护理系统和资金复杂性。突出的实现促进因素包括学习协作、技术集成和明确的契约语言。实施当日暴露前预防的主要制约因素包括资金不公平和客户/患者意识不佳,而促进因素包括综合护理模式、入门包的可用性和药物援助计划。结论:尽管背景不同(例如,医疗补助扩张),但几个一致的关键障碍和促进因素跨越了多个结束艾滋病毒流行的司法管辖区。系统领导者和服务提供者之间的协作努力被普遍认为是公平采用和渗透快速START模式的必要条件。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.80
自引率
5.60%
发文量
490
审稿时长
3-6 weeks
期刊介绍: JAIDS: Journal of Acquired Immune Deficiency Syndromes​ seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide. JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信